Gain Therapeutics, Inc. (GANX)

CIK 1819411 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gain Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 30, 202630001104659-26-120731
Oct 30, 202640001104659-26-120734
Oct 28, 20268-K0001104659-26-119673
Oct 1, 20268-K0001104659-26-112624
Sep 28, 20268-K0001104659-26-111391
Aug 11, 202610-Q0001104659-26-094048
Aug 11, 20268-K0001104659-26-094041
Jul 17, 202640001104659-26-084435
Jul 17, 202640001104659-26-084437
Jul 17, 202640001104659-26-084438
Jul 17, 202640001104659-26-084433
Jul 17, 202640001104659-26-084434
Jul 17, 202640001104659-26-084439
Jul 16, 20268-K0001104659-26-084086
Jun 29, 20268-K0001104659-26-078848
Jun 25, 20268-K0001104659-26-077820
May 26, 20268-K0001104659-26-066062
May 11, 20268-K0001104659-26-058636
May 11, 202610-Q0001104659-26-058649
Apr 28, 2026ARS0001104659-26-050437
Apr 28, 2026DEF 14A0001104659-26-050431
Apr 28, 2026DEFA14A0001104659-26-050435
Mar 26, 20268-K0001104659-26-035174
Mar 26, 202640001104659-26-035403
Mar 26, 202640001104659-26-035400